Seventy-sixpatients(85.3%;n=41forsildenafilandn=35forplacebo)completedallbaselinetoweek6endpointassessments;datafor5placebopatientswerediscontinuedforlackofefficacyandwerelosttofollow-up().<ahref="https://viagraoktobuy.com/">buyviagraonline</a>Piperazineswerecreatedinthe-VaultsofErowid-NIDA,DrugFacts,drugabuse.